Search

everythinglearnresearchcommunity

for

Search:↓

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

Long-term use of dutasteride can cause permanent erectile dysfunction in rats.

Finasteride raises suicide-linked aggression and stops clozapine's positive effects in schizophrenia animals.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

Inhibiting 5α-reductase increases progesterone levels in late pregnant mares.

UHP-sCESr is as effective as HESr for treating BPH symptoms.

Finasteride reduces some inflammation in BPH but not all.

Dutasteride is more effective than Finasteride in reducing prostate size and PSA levels, but both drugs have similar side effects.

Plant extracts effectively reduce hair loss and increase growth, offering a safe alternative treatment.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Females with 5 alpha-reductase-2 deficiency have less body hair, no acne, normal fertility, and delayed menarche.

Different mutations in the 5 alpha-reductase-2 gene were found in affected individuals in the Dominican Republic, suggesting no common ancestry.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

Finasteride negatively affects fish reproduction and gonadal development.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

Methylated gene parts may cause finasteride-resistance in some enlarged prostate patients.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Special nanoparticles increased skin absorption of hair loss treatments with fewer side effects.

Sleep, testosterone levels, and a specific enzyme activity affect skin oil production in women.

A topical treatment safely and effectively reduced acne by causing targeted cell death in sebaceous glands without side effects.

The document concludes that women should not use 5-alpha-reductase inhibitors due to the risk of birth defects and limited effectiveness.

Finasteride, when given in high oral doses to pregnant monkeys, caused genital abnormalities in male fetuses, but not in female fetuses or those exposed to intravenous finasteride.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

LH and hCG reduce certain protein levels in women's skin.